Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric symptoms and Functional Impairment in Alzheimer Disease
JAMA 289:210-216, Trinh,N.,et al, 2003
Treatment of Refractory Myasthenia: "Rebooting" with High-Dose Cyclophosphamide
Ann Neurol 53:29-34,7, Drachman,D.B.,et al, 2003
Resolved: Heparin May Be Useful in Selected Patients with Brain Ischemia
Stroke 34:230-231, Caplan,L.R., 2003
Neurological Aspects of Biological and Chemical Terrorism
Arch Neurol 60:21-25, Martin,C.O., &Adams,H.P., 2003
Treatment of Sporadic Hemiplegic Migraine with Calcium-Channel Blocker Verapamil
Neurol 60:120-121, Yu,W. &Horowitz,S.H., 2003
Primary Brain Tumours in Adults
Lancet 361:323-331, Behin,A.,et al, 2003
The Use of Topiramate in Refractory Status Epilepticus
Neurol 60:332-334, Towne,A.R.,et al, 2003
Practice Parameter: Treatment of the Child with a First Unprovoked Seizure
Neurol 60:166-175, Hirtz,D.,et al, 2003
Transient Suppression of Tinnitus by Transcranial Magnetic Stimulation
Ann Neurol 53:263-266, Plewnia,C.,et al, 2003
Alcohol Consumption and Risk of Stroke
JAMA 289:579-588, Reynolds,K.,et al, 2003
The Neurobiology, Diagnosis, and Treatment of Narcolepsy
Ann Neurol 53:154-166, Scammell,T.E., 2003
Acetylcholinesterase Inhibitors for Vascular Dementia and Alzheimer's Disease Combined With Cerebrovascular Disease
Stroke 34:584-586, Bowler,J.V., 2003
Reanalysis of the Final Results of the European Carotid Surgery Trial
Stroke 34:514-523, Rothwell,P.M.,et al, 2003
An Organic Cause of Neuropsychiatric Illness in Adolescence
Lancet 361:572, Taylor,S.E.,et al, 2003
Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003
Clinicopath Conf., Chronic Inflammatory Demyelinating Polyneuropathy
NEJM 348:735-743, Case 6-2003, 2003
Development of Generalized Disease at 2 Years in Patients with Ocular Myasthenia Gravis
Arch Neurol 60:243-248, Kupersmith,M.J.,et al, 2003
Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003
Hashimoto Encephalopathy
Arch Neurol 60:164-171, Chong,J.Y.,et al, 2003
Reversal of Parkinsonism Following Liver Transplantation
Neurol 60:519, Shulman,L.J.,et al, 2003
Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003
Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003
Outcome in Psychogenic Nonepileptic Seizures: 1 to 10-Year Follow-up in 164 Patients
Ann Neurol 53:305-311,285, Reuber,M.,et al, 2003
Practice Parameter: Temporal Lobe and Localized Neocortical Resections for Epilepsy
Neurol 60:538-547, Engel,J.,et al, 2003
Myotonic Dystrophy Type 2
Neurol 60:657-664, Day,J.W.,et al, 2003
Intranasal Sumatriptan in Cluster Headache
Neurol 60:630-633, van Vliet,J.A.,et al, 2003
Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection Devices
Stroke 34:813, Kastrup,A.,et al, 2003
Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003
Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003
Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003
Audiovestibular Manifestations in Giant Cell Arteritis: A Prospective Study
Medicine 82:13-26, Amor-Dorado,J.C.,et al, 2003
Paraplegia After Ligation of Esophageal Varices
Neurol 60:879, Debette,S.,et al, 2003
Peri-ictal Water Drinking Lateralizes Seizure Onset to the Nondominant Temporal Lobe
Neurol 60:873-876, Trinka,E.,et al, 2003
Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol 60:322-328, Wegner,D.A.,et al, 2003
Hypnic Headache, Clinical Features, Pathophysiology, and Treatment
Neurol 60:905-909, Evers,S.&Goadsby,P.J., 2003
Painful Sensory Neuropathy
NEJM 348:1243-1255, Mendell,J.R.&Sahenk,Z., 2003
Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
NEJM 348:1223-1232, 1279, Rowbotham,M.C.,et al, 2003
Chronic Low Back Pain
BMJ 326:535, Samanta,J.,et al, 2003
Neurological Aspects of Taste Disorders
Arch Neurol 60: 667-671, Heckmann,J.G.,et al, 2003
Stem Cells and Neurological Disease
JNNP 74:553-557, Barker,R.A.,et al, 2003
Randomized Trial of Pallidotomy Versus Medical Therapy for Parkinson's Disease
Ann Neurol 53:558-569, Vitek,J.L.,et al, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Pacemaker Therapy for Prevention of Syncope in Patients with Recurrent Severe Vasovagal Syncope
JAMA 289:2224-2229,2272, Connolly,S.J.,et al, 2003
Vertebral Artery Origin Angioplasty and Primary Stenting: Safety and Restenosis Rates in a Prospective Series
JNNP 74:586-590, Cloud,G.C.,et al, 2003